STN: BL 125363/0
Proper Name: Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine
Trade Name: MenHibrix
Manufacturer: GlaxoSmithKline Biologicals
- Indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b for children 6 weeks of age through 18 months of age.